PKC-B inhibition: a new therapeutic approach for diabetic complications?
about
Presence and Risk Factors for Glaucoma in Patients with Diabetes.Proteomic Analysis of Vascular Endothelial Cells-Effects of Laminar Shear Stress and High Glucose.RhoA/rock signaling mediates peroxynitrite-induced functional impairment of Rat coronary vesselsDiabetes-induced increased oxidative stress in cardiomyocytes is sustained by a positive feedback loop involving Rho kinase and PKCβ2.High glucose induces adipogenic differentiation of muscle-derived stem cells.Molecular sources of residual cardiovascular risk, clinical signals, and innovative solutions: relationship with subclinical disease, undertreatment, and poor adherence: implications of new evidence upon optimizing cardiovascular patient outcomes.The Heart and Medicine: Exploring the Interconnectedness of Cardiometabolic-related Concerns Through a Systems Biology ApproachProtein kinase C βII in diabetic complications: survey of structural, biological and computational studies.Protein kinase C inhibitors: a patent review (2010 - present).Design, synthesis, and investigation of protein kinase C inhibitors: total syntheses of (+)-calphostin D, (+)-phleichrome, cercosporin, and new photoactive perylenequinones.Intra- and extrarenal arteries exhibit different profiles of contractile responses in high glucose conditions.Non-ATP-competitive kinase inhibitors - enhancing selectivity through new inhibition strategies.Blockade of chronic high glucose-induced endothelial apoptosis by Sasa borealis bamboo extract.Differential activations of PKC/PKA related to microvasculopathy in diabetic GK rats.Targeting PKC-β II by Peptides and Peptidomimetics Derived from RACK 1: An In Silico Approach.PKCβ inhibition with ruboxistaurin reduces oxidative stress and attenuates left ventricular hypertrophy and dysfunction in rats with streptozotocin-induced diabetes.
P2860
Q30244246-B7AE46C0-D630-423A-A681-7C56B6809AB6Q33637397-2AF28F75-0747-4EA9-B1A1-4ED938AAF5B1Q36159672-ADE8654B-5C7C-4A2F-A1CF-42B0E38FDC37Q36312528-3B03B127-9669-406A-9C61-280E8A5BF7C2Q36446142-8543F506-23E4-4394-8EE9-A5F1CF254308Q37254899-2B2F41CF-E2AF-464A-83AB-FC1AB576E0BFQ37323846-FE4C98BE-2762-4048-B7BB-4B6893E1F2D2Q37992101-B63EC532-9757-4622-B54F-2F5BDB0B2F60Q38116565-7F92B4A6-BD01-4FE3-8F43-23F21284B98DQ39843967-711345C1-A353-4565-AD0B-B4DACCCDC25DQ41893656-1D13B738-2492-48AD-8DCE-2494F8B3787EQ43878954-67E73714-6D01-4B00-AA24-5F0760AB6181Q46674564-8924721E-2CC0-42FE-A078-F6F400CEAEDFQ48850018-B389805B-CE66-4088-9001-DCF8553FDB1CQ51610419-D4249FB2-C825-4D8B-8B90-E91293113E0DQ54563159-30BE5403-43CA-45F1-A217-8F8DD320ECE6
P2860
PKC-B inhibition: a new therapeutic approach for diabetic complications?
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@ast
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@en
type
label
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@ast
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@en
prefLabel
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@ast
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@en
P1476
PKC-B inhibition: a new therapeutic approach for diabetic complications?
@en
P2093
P304
P356
10.1016/S1262-3636(07)70270-7
P577
2006-06-01T00:00:00Z